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Abstract Canine distemper virus (CDV) causes severe
immunosuppression and neurological disease in dogs,
associated with demyelination, and is a model for mul-
tiple sclerosis in man. In the early stage of the infection,
demyelination is associated with viral replication in the
white matter. In acute demyelinating lesions there is
massive down-regulation of myelin transcription and
metabolic impairment of the myelin-producing cells, but
there is no evidence that these cells are undergoing
apoptosis or necrosis. Oligodendroglial change is related
to restricted infection of these cells (transcription but no
translation) and marked activation of microglial cells in
acute lesions. Concomitant with immunological recov-
ery during the further course of the disease, inﬂamma-
tion occurs in the demyelinating plaques with
progression of the lesions in some animals. A series of
experiments in vitro suggests that chronic inﬂammatory
demyelination is due to a bystander mechanism resulting
from interactions between macrophages and antiviral
antibodies. Autoimmune reactions are also observed,
but do not correlate with the course of the disease. The
progressive or relapsing course of the disease is associ-
ated with viral persistence in the nervous system. Per-
sistence of CDV in the brain appears to be favored by
non-cytolytic selective spread of the virus and restricted
infection, in this way escaping immune surveillance in
the CNS. The CDV Fusion protein appears to play an
important role in CDV persistence. Similarities between
canine distemper and rodent models of virus-induced
demyelination are discussed.
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Introduction
Epidemiological observations strongly suggest that
multiple sclerosis (MS) is a disease caused by an
infectious agent that induces an immune-mediated
demyelinating disease [9, 54]. While much progress has
been made in recent years, the pathogenesis of MS is
still unclear, and animal models of viral demyelination
remain important tools in MS research. The fact that
the mouse genome has been sequenced and that
transgenes can be routinely produced has greatly ad-
vanced the use of this species in pathogenesis research.
This is also true for infectious diseases including virus-
induced demyelination [22, 62]. While none of the
rodent models truly resemble MS, a variety of widely
diverging mechanisms of virus-induced demyelination
have been elaborated in these animals. This diversity is
not surprising since infectious diseases are generally
the result of co-evolution of infectious agents and their
hosts, and their pathogenesis is determined by highly
complex interactions. Such interactions involve adap-
tation of the agent to host cells, speciﬁc tropism,
neuro-invasiveness, anti-virus immune response, etc.
Therefore, it can be hardly expected that an exact
replica of MS could be reproduced in a single viral
model, and it makes sense to investigate various spe-
cies-agent combinations, including diseases in larger
animals.
A spontaneous MS-like disease with multifocal
demyelinating lesions is rare in domestic animals, in
which systematic neuropathological screening has been
performed for at least half a century in various labs
around the world. While such studies focused to a
large extent on companion animals, the creation of
surveillance systems to control the BSE outbreak in
Europe during the past two decades led to the histo-
logical examination of hundreds of thousands of
ruminant brains, considerably increasing the database
on large animal neuropathology. Primary demyelina-
tion in domestic animals has only been observed for
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Visna, a lentivirus infection in sheep and in canine
distemper virus (CDV) infection. While demyelination
is a rare complication in the former, it occurs with
very high frequency in distemper. Canine distemper
has been recognized as a disease entity for over two
hundred years. The ﬁrst description of demyelination
in this disease originates from 1877 by Gowers and
Sankey [53]. This canine lesion continued to fascinate
human neuropathologists such as H.J. Scherer [55],
who quite boldly described it as: ‘‘acute multiple
sclerosis of the dog’’.
Canine distemper virus
Despite widespread use of vaccination, distemper con-
tinues to be a problem with outbreaks occurring in ca-
nine populations, but also in other species such as seals
and lions [8, 31, 49]. CDV is an enveloped, non-seg-
mented, single-stranded RNA virus and is a member of
the morbilliviruses, thus closely related to measles virus.
CDV possesses a nucleocapsid containing the viral
genome, which consists of the nucleoprotein (N) and the
polymerase complex including the P and L proteins. The
membrane protein (M) is located at the inner surface of
the envelope, which exhibits two surface glycoproteins :
the attachment protein (H) and the fusion protein (F).
The cellular receptor for the H protein in vivo has not
been determined. CD9 acts as a receptor for attenuated
CDV in cell lines but not for virulent CDV [41]. The
signaling lymphocyte activation molecule (SLAM) was
shown to be a very eﬃcient receptor for wild CDV [59]
in canine SLAM transfected tissue cultures, in which
wild CDV can normally only be propagated following
repeated passages. However, immunocytochemical
studies showed only very limited expression of SLAM in
the CNS, as compared to lymphoid tissues (studies in
progress). Therefore, it is probable that other viral
receptors exist.
CDV in dogs is generally transmitted as an aerosol
infection to the upper respiratory tract. Primary virus
replication takes place in the lymphoid tissues
(Fig. 1A), leading to severe long-lasting immunosup-
pression [5, 37, 39]. T cells are more aﬀected than B
cells [35], and CD4+ lymphocytes are rapidly depleted
for several weeks [70], probably by virus induced
apoptosis [40. 46], whereas CD8+ cells are less severely
aﬀected and recover relatively fast [70]. At about
10 days post infection (p.i.), CDV starts to spread from
sites of primary replication to various epithelial tissues
(Fig. 1B) and the central nervous system (CNS). As a
result of epithelial infection, respiratory, intestinal and
dermatological signs can occur. The most serious
complication is infection of the CNS, leading to a
variety of neurological syndromes, frequently with bad
prognosis [68]. Neurological signs often occur in the
absence of systemic signs. In the following we present a
review of what is known about the neuropathology of
CDV infection in its natural host, the dog.
Neuropathology of nervous distemper
While strain variation and related diﬀerences in lesion
patterns exist [65], in the vast majority of spontaneous
distemper cases and in experimental studies with so-
called ‘‘demyelinating’’ strains such as R252 [43] and
A75/17 CDV [64], the virus causes multifocal lesions in
the gray and white matter of the CNS [67]. Generally,
demyelinating lesions prevail, and gray matter lesions
may be lacking. The predilection sites are the white
matter of the cerebellum, the periventricular white
matter, especially around the fourth ventricle, the optic
pathways and the spinal cord (Fig. 1B). CDV enters the
brain by infected mononuclear cells penetrating the
blood barrier but, possibly more importantly, by circu-
lating in the CSF (Fig. 1E) and fusing with the epen-
dymal lining of the ventricles [33]. This explains the
frequent periventricular and subpial location of the le-
sions. In the following sections, we will focus on what is
known about the pathogenesis of the white matter le-
sions in distemper.
Pathogenetic studies have to consider an acute and a
chronic stage in the development of CDV-induced
demyelination. The initial demyelinating lesions occur
around 3 weeks p.i. and evolve during a period of
massive virus-induced immunosuppression [72].
Depending on the degree and speed of immune recovery,
animals may either become quickly moribund or may
recover after developing a mild or even subclinical ill-
ness. An intermediate group of animals recovers slowly
or partially, and tends to develop a chronic or even
relapsing disease [10, 34] with progression of the demy-
elinating lesions as a result of immunopathological
reactions [71, 73].
The acute stage of distemper: virus-induced
demyelination
Infection of the glial cells of the white matter
The initial myelin lesions develop during a period of
severe immunosuppression and are not inﬂammatory
[72] in the traditional sense of the word, since perivas-
cular cuﬀs are entirely lacking. Initial lesions are char-
acterized by ballooning of myelin sheets with
vacuolation of the white matter, myelin phagocytosis
and astrocytic swelling (Fig. 2A). Several immunocyto-
chemical studies and in situ hybridization work in
spontaneous and experimental distemper have clearly
shown that demyelination coincides with replication of
CDV in the glial cells (Fig. 1C, D, F) of the white matter
[75, 83]. Spatio-temporal studies leave no doubt that the
initial white matter lesions are associated with viral
activity and that their development is highly predictable
[32, 33, 64, 75]. The obvious explanation for the phe-
nomenon of demyelination would be infection of oli-
godendrocytes. A primary insult to the oligodendrocyte
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is strongly supported by the ﬁnding of segmental
demyelination in distemper by Higgins et al. [33].
Therefore, research has focused on ﬁnding evidence of
CDV in oligodendrocytes. At the light microscopic level,
it has been shown that the majority of infected cells in
the white matter are astrocytes [48]. Most electron
microscopical studies agree that oligodendroglial infec-
tion is very rare in distemper [13, 33, 52, 63, 78].
Immunocytochemical staining for CDV combined with
in situ hybridization for proteolipid protein (PLP)
messenger RNA showed only very few oligodendrocytes
containing CDV protein (Fig. 2E). However, approxi-
mately 8% of the oligodendrocytes (Fig. 2F) at the edge
of lesions contained CDV mRNA [85]. A restricted
infection of oligodendrocytes with viral transcription
but no translation (Fig. 4) had been found earlier in dog
Fig. 1 CDV infection. A At 6
days p.i., massive virus
replication in thymus is seen; in
situ hybridization for CDV N
mRNA. B At 10 days p.i.,
widespread infection in
epidermis is seen; immune-
staining for CDV (red), anti-
CDV N-ABC. C At 21 days p.i.
widespread infection is seen in
white matter of cerebellum; in
situ hybridization for CDV N
mRNA. D Non-cytolytic
astrocytic infection is seen in
white matter; in situ
hybridization for CDV N
mRNA. E Infection of choroid
plexus, ependyma and
subependymal cells around
IVth ventricle is seen; in situ
hybridization for CDV N
mRNA. F Acute demyelination
with vacuolation of white
matter coinciding with
productive infection in glial
cells, immunostaining for CDV
with anti-CDV-PAP (CDV
canine distemper virus, p.i. post
infection, PAP peroxidase-
antiperoxidase). A, C, E ·40; B
·200; D ·400; F ·100
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brain cell cultures [83], in which virulent CDV causes a
slowly spreading non-cytolytic infection. CDV proteins
or viral nucleocapsids were only very rarely found in
oligodendrocytes in culture (Fig. 3A, B), in contrast to
astrocytes and microglial cells which easily support
productive CDV infection [74, 81, 82]. Thus, we con-
cluded from these studies in vivo and in vitro that CDV
causes a restricted infection of the oligodendrocytes.
Why the production of viral protein does not take place
in these cells remains to be clariﬁed.
Changes in oligodendrocytes
Between 20 and 30 days p.i., cultured canine oligoden-
drocytes, which grow superimposed on a layer of as-
trocytes in mixed dog brain cell cultures, start to
degenerate (Fig. 3C, D), and after several weeks can no
longer be detected with immunocytochemical stains for
myelin proteins, although the supporting culture re-
mains a continuous cell sheet [82]. Ultrastructural
studies revealed microvacuolation and loss of organelles
in such oligodendrocytes [23]. These morphological
changes are preceded by metabolic dysfunction of these
cells: cerebroside-sulfo transferase activity (an oligo-
dendrocyte-speciﬁc enzyme) decreased markedly soon
after infection [23], and myelin transcription is soon
strongly decreased (Fig. 4E) in infected brain cell cul-
tures [24]. In vivo, we could also show that CDV
infection led to massive down-regulation of myelin gene
transcription with complete loss of in situ hybridization
signals for PLP in oligodendrocytes (Fig. 2C) in early
demyelinating lesions [85]. Demyelination is apparent
before oligodendrocytes disappear in the aﬀected white
matter area as seen on immunocytochemical staining
(Fig. 2D) for CNPase, an oligodendrocyte-speciﬁc en-
zyme [58]. Some oligodendrocytes appeared to be
hypertrophic (Fig. 2G). The fate of the oligodendro-
Fig. 2 Acute demyelination in distemper. A At 20 days p.i., acute
white matter lesion with vacuolation and astrocytic hypertrophy
are seen; hematoxylin and eosin. B At 24 days p.i., a demyelinating
plaque in the cerebellum is seen; immunohistological stain anti-
MBP-PAP. C At 21 days p.i., a demyelinating lesion with marked
loss of PLP mRNA staining (blue) of oligodendrocytes; in situ
hybridization for PLP m RNA, immunostaining for CDV (brown)
with anti-CDV NP-PAP. D At 30 days p.i., advanced lesion with
massive loss of myelin is seen. Many oligodendrocytes are still
visible in the lesion; immunostaining with anti-CNP-ABC. E
Double labeling for CDV (anti-CDV-PAP, brown) and oligoden-
drocytes (in situ for PLP mRNA, blue). Colocalization of CDV and
oligodendrocyte (arrow). F Edge of demyelinating lesion. Double in
situ hybridization for PLP mRNA (black) and CDV N mRNA
(red), colocalization of virus and oligodendrocytes (arrow). G
Hypertrophic oligodendrocyte in demyelinated area, anti-CNP-
ABC (PLP proteolipid protein). A ·250; B, C ·40; F ·400; G
·1,200
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cytes, however, remains unclear. Morphological changes
of oligodendrocytes were described in demyelinating le-
sions in vivo using electron microscopy [13, 63], but
there is no concrete evidence that these cells undergo
necrosis or apoptosis [57, 58]. There is little doubt that a
change of these cells lies at the base of the demyelinating
process but its mechanism is not yet understood. It is
possible that viral transcription taking place in these
cells interferes with specialized functions necessary to
maintain myelin membranes.
In summary, acute CDV infection of the white matter
results in metabolic oligodendroglial changes which lead
Fig. 3 CDV infection in canine
brain cell cultures. A Infection
of astrocytes; double
immunoﬂuorescence labeling
with anti-CDV (green) and anti-
GFAP (red). B Double indirect
immunoﬂuorescence labeling
with anti-CDV (green) and anti-
MAG (red) for
oligodendrocytes, no CDV
protein in oligodendrocytes. C
Normal morphology of
oligodendrocytes in uninfected
culture, anti-MAG (brown) +
anti-O4 (blue)-PAP. D
Degenerating oligodendrocytes
in infected culture 25 days p.i.,
ﬂattening and shortening of cell
processes is seen; anti-MAG-
PAP (GFAP glial ﬁbrillary
acidic protein, MAG myelin-
associated glycoprotein). A, B
·200; C, D ·400
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to demyelination. Whether the dysfunction of the oli-
godendrocyte is the direct result of restricted CDV
infection, which has been shown in these cells, remains
to be shown. This correlation is apparent in brain cell
cultures [24], but since restricted infection in vivo af-
fected less than 10% of the oligodendrocytes in demye-
linating lesions it can not be easily explained why myelin
loss in infected white matter areas is nearly complete.
Activation of microglia
It cannot be excluded that oligodendrocytes are af-
fected as a result of virus-induced changes in other cell
types. Alldinger at al. [3] found a diﬀuse MHC class II
up-regulation in the white matter, presumably in the
microglial cells, in the early stages of distemper.
Activation of microglial cells with release of toxic
factors could induce myelin damage. In earlier exper-
iments, we found that supernatants derived from
CDV-infected dog brain cell cultures (DBCC) did not
induce oligodendroglial lesions in recipient dog or
mouse brain cultures [82]. However, extensive treat-
ment of the supernatants to remove infectious virus
may have contributed to these negative results. We
were also unable to ﬁnd signiﬁcant amounts of toxic
factors such as TNF-a or reactive oxygen radicals in
the supernatants of CDV-infected DBCC [16]. This
may have been due to the fact that microglial cells in
mixed brain cell cultures pose only a small fraction of
the total cell population. Recently, we developed
puriﬁed canine microglial cell cultures and found that
the activity of ex vivo cultivated microglial cells from
dogs with experimentally induced demyelinating dis-
temper exhibited a greatly enhanced expression of
MHC and adhesion molecules, phagocytic activity and
oxygen radical production. This appeared to be di-
rectly related to CDV infection of these cells [60].
These ﬁndings are consistent with our previous
observations according to which procoagulant activity
is enhanced in cultivated CDV-infected macrophages
[16]. It is not inappropriate to speculate that CDV-
induced microglial cell activation could contribute to
oligodendrocyte/myelin damage. This view is sup-
ported by experiments in mixed brain cell cultures in
which stimulation of microglial cells (Fig. 6A, B) led
to considerable damage to the oligodendroglial cells
[15, 29].
Immune response in early lesions
In view of the massive virus-induced immunosuppres-
sion in distemper soon after infection, we assumed for a
long time that humoral and cellular immune responses
could hardly play a role in early lesion development.
However, several ﬁndings cast some doubt on our ori-
ginal view that initial lesions are purely virus induced.
While an eﬀective anti-viral neutralizing immune re-
sponse is indeed completely lacking in the acute phase of
distemper, anti-CDV IgM antibodies occur within the
ﬁrst 2 weeks of infection [11]. Despite lack of perivas-
cular cuﬃng, numerous CD8+ cells are found in acute
demyelinating lesions (Fig. 5A–C) and also diﬀusely
distributed in the brain parenchyma, roughly correlating
with areas of viral infection [69]. In the CSF of animals
Fig. 4 Restricted infection of oligodendrocytes. A–D Immunoﬂu-
orescence staining for myelin proteins combined with in situ
hybridization for CDV m RNA; video microscopy. A Anti-MAG-
FITC, B same cell as in A, in situ for CDV N mRNA. C Anti-
MBP-FITC. D Same cell as in C; in situ for CDV F mRNA. E
Densitometric assessment of MBP mRNA in dog brain cell
cultures, strong down-regulation of MBP transcription in CDV-
infected cultures (MBP myelin basic protein). A–D ·400
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with acute myelin lesions, high IL-8 titers are found [69].
It was suggested that initial microglial cell activation as
discussed above may trigger invasion of T cells in the
CNS [69]. Of interest in this respect is that metallopro-
teinases and their inhibitors appear to be strongly up-
regulated in acute and subacute lesions in distemper [45].
Systemic antiviral cytotoxic immune reactions have only
been shown in the later stage of CDV infection [7].
Invading T cells in acute lesions do not appear to have
an obvious impact on CDV-infected cells since sequen-
tial studies showed that the viral load continues to in-
crease until a full inﬂammatory response develops in the
frame of immune recovery [69]. Others have shown that
in dogs with demyelinating distemper, pro-inﬂammatory
cytokines are up-regulated, while anti-inﬂammatory
cytokines remain at a base line level [42]. Cytokine up-
regulation in CNS cells is probably directly virus in-
duced as shown in experimentally infected primary brain
cultures [30].
The chronic stage of distemper: inflammatory
demyelination
Coinciding with the recovery of the immune system 6–
7 weeks p.i., perivascular cuﬃng with lymphocytes,
plasma cells and monocytes (Fig. 5D) occurs in the
initial virus-induced brain lesions [71]. The inﬂammatory
reaction in the demyelinating lesions can lead to pro-
gression of tissue damage [73, 78]. There is often frank
necrosis of the tissue in such lesions. Thus, the chronic
stage of the disease is characterized by immunopatho-
logical complications. During immune recovery, a ma-
ture immune reaction develops by perivascular
inﬁltration of CD4+ cells and subsequent recruitment of
large numbers of plasma cells and strong intrathecal
antibody synthesis [69, 71, 76, 79]. In inﬂammatory le-
sions, pro-inﬂammatory cytokines are markedly up-
regulated, whereas anti-inﬂammatory cytokines remain
Fig. 5 Immune-response in the
CNS in distemper. A–C Acute
demyelinating lesion in anterior
medullary velum. A In situ for
CDV N mRNA. B Anti-CD18-
PAP, up-regulation of
microglial cells. C Anti-CD3-
PAP, many diﬀusely invading T
cells. D At 40 days p.i.,
inﬂammatory demyelination
around fourth ventricle is seen;
myelin stain (Luxol-fast blue).
E CDV clearance in
inﬂammatory focus in spinal
cord (arrow) and many CDV-
containing cells in surrounding
tissue are seen; anti-CDV N-
PAP. A–C, E ·100; D ·200
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at normal levels [42]. It is possible that astrocytes, a
primary target of CDV, participate in the ampliﬁcation
of the immune response. Astrocytes exhibit up-regulated
CD44 in their cell membranes in distemper [4] and were
shown to loose beta 2 adrenergic receptors [20].
Tissue destruction is related to the antiviral immune
response
The titers of CDV neutralizing antibodies in the CSF
often exceed those in the serum [14]. Binding studies
show that antibodies are made against all proteins of
CDV [36]. The occurrence of anti-CDV antibodies in the
CSF coincided with clearance of CDV (Fig. 5E)—and
CDV-containing cells—from the inﬂammatory lesions
[2, 12, 14]. In chemiluminescence experiments in brain
cell cultures, we found that antiviral antibodies, derived
from serum and CSF, bound to the surface of CDV-
infected cells, interacted with the Fc receptors of
neighboring macrophages, inducing a respiratory burst
with release of reactive oxygen radicals [17, 26, 27]
(Fig. 6C, D). We also showed that stimulation of mac-
rophages in brain cell cultures in various ways including
Fig. 6 Macrophage stimulation
in brain cell cultures. A
Oligodendrocytes in normal
untreated culture; anti-
galactocerebroside-FITC. B
Oligodendrocytes 48 h
following macrophage
stimulation with zymosan,
showing marked loss of cell
processes; anti-
galactocerebroside-FITC. C
Proximity of microglial cell
labeled with opsonized
erythrocytes and
immunostained (anti-MAG-
FITC) oligodendrocyte. D
Chemiluminescence following
treatment of brain cultures with
anti-CDV antibodies derived
from dogs with distemper,
showing marked respiratory
burst (open squares: uninfected
culture, full squares: CDV-
infected culture). A, B ·200; C
·400
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antiviral antibody-virus immune complexes led to
selective destruction of oligodendrocytes in their vicinity
[15, 29] (Fig. 6A, B). Thus, these experiments showed
how the humoral antiviral immune response could lead
to destruction of oligodendrocytes as ‘‘innocent by-
stander’’ cells. Obviously, several products secreted by
stimulated macrophages, including reactive oxygen
radicals can be made responsible for damage to the
oligodendrocyte/myelin compartment. Chemically
produced reactive oxygen radicals in the xantine/xan-
tine-oxydase system, which was added to the culture
supernatant, selectively damaged cultured oligodendro-
cytes [28] which are rich in iron compounds [25], ren-
dering these cells particularly vulnerable to oxygen
radical attack. The observed marked up-regulation of
microglial/macrophage activity in CDV infection [16,
60], as discussed earlier in this paper, may enhance the
destructive potential of these cells, and provide further
support for the hypothesis that bystander demyelination
occurs in chronic distemper. The experimental condi-
tions in the antibody experiments in vitro closely mimic
the situation in vivo, in which CDV-infected glial cells in
the white matter are in close contact with macrophages
and antiviral antibody-producing cells. Therefore, it is
not unreasonable to conclude that a bystander mecha-
nism associated with the antiviral immune response can
be made responsible for the progression of demyelinat-
ing lesions in the chronic stage of CDV infection.
Virus-induced autoimmunity in distemper?
Anti-myelin antibodies in serum have been known for a
long time to occur in distemper [38]. We also observed
such antibodies in the CSF of dogs with distemper, and
found that these antibodies are locally produced in the
inﬂammatory brain lesions [76]. A cell-mediated re-
sponse against myelin basic protein (MBP) was found in
4 of 11 dogs experimentally infected with CDV [18].
However, neither anti-myelin antibodies nor cell-medi-
ated anti-myelin reactions correlated with the course of
the disease. In addition, distemper has no resemblance
to EAE in dogs [66].
Further progression of the disease: virus persistence
The antiviral immune response should be beneﬁcial to
the host in that CDV is removed from the tissue [14].
However, our studies also showed that CDV can persist
in white matter areas outside of the inﬂammatory
demyelinating lesions [14]. It appears therefore that a
chronic progressive disease develops if the intrathecal
immune response keeps lagging behind viral replication.
Thus, virus persistence is the key to the pathogenesis of
the chronic lesion. Persistence of measles virus, which is
closely related to CDV, in the CNS of humans appears
to be associated with the production of defective viruses
[56]. Although a restricted expression of surface proteins
in the CNS has been suggested in immunocytochemical
studies [2], all viral RNAs and proteins are expressed in
the CNS in relative proportions consistent with the
particular transcription mode of morbilli viruses [47].
Thus, there is no evidence for defective viruses in CDV
infection. Rather, persistence of CDV could be related
to restricted infection and non cytolytic spread.
Restricted infection
As described above, CDV infects oligodendrocytes in
vitro and in vivo with transcription of the entire viral
genome, but very little translation of viral proteins. Such
a restricted infection is also detected in neurons in which
viral RNA was readily found in the absence of protein
expression [47]. In this way, a viral reservoir is created,
escaping immunodetection of CDV. It is conceivable
that the virus can be reactivated with establishment of a
productive infection, precipitating a new episode of
inﬂammation and demyelination.
Non-cytolytic selective spread
Another factor favoring persistence is the fact that vir-
ulent CDV in vivo and in vitro causes a non-cytolytic
infection, limiting the exposure of local immune cells to
CDV antigens. To investigate mechanisms of persis-
tence, we have compared several biological and molec-
ular features between the wild persistent virus and an
attenuated CDV which does not persist. We found that
persistent CDV spreads in primary brain tissue cultures
in a non-cytolytic heterogeneous manner with very
limited release of infectious virus [84] as compared to
attenuated viruses, which spread in a concentric cyto-
lytic pattern through massive release of viral particles
(Fig. 7A, B). Both lack of cytolysis and little shedding of
virus in the extracellular space in the CNS would appear
to limit activation of the local immune response, thus
favoring persistence.
Ultrastructurally, persistent CDV was found to pro-
duce only few viral buds as compared to non-persistent
CDV [44]. The strongly reduced production of viral
particles in limited areas of the cell membrane, explains
by itself the heterogeneous infection pattern with single
infected cells amidst uninfected ones. This pattern is
even more pronounced in CNS cells possessing long
processes further increasing the spacing between infected
cells and rendering the impression that infection is
transmitted by way of cell processes (Fig. 7C). The
budding process of morbilli viruses is quite complex and
requires speciﬁc spatial arrangements of the viral pro-
teins at the cell membrane [50]. Confocal microscopical
studies revealed a limited colocalization of F and H
(Fig. 7E, F), both surface proteins of CDV, in the per-
sistent infection as compared to the non-persistent virus
where H and F were always colocalized [44]. Infection
experiments with vaccinia constructs, containing either
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F gene of persistent or non-persistent CDV revealed an
additional large fraction of uncleaved F protein in the
persistent infection (Fig. 7D), indicating clear diﬀer-
ences in intracellular processing of the F protein between
the two CDV strains [44].
In addition to limited release of infectious virus, there
is a paucity of cell-cell fusion in the persistent infection,
in contrast to the non-persistent virus, which induces
large cytolytic syncytia [44]. In measles virus it has been
established that cytolysis occurs when a critical number
of cells are fused [21]. Thus, lack of cytolysis is related to
lack of cell-cell fusion. We concluded from our studies
that persistence appears to be related to very limited
expression of fusogenic complexes in the cell membrane.
Limited budding and lack of cell-cell fusion may have a
common denominator in the conﬁguration and pro-
cessing of the F protein.
Molecular determinants of viral persistence
Since sequencing studies have shown diﬀerences between
virulent and attenuated CDV at the level of all genes
([19, 61]; Gene bank AF164967), it is hardly feasible to
relate persistence to single molecular determinants. In
view of the ﬁndings described above, attention has been
focused on the F protein. The primary transcript of the
F protein consists of a precursor protein containing a
Fig. 7 CDV persistence in
vitro. A Non-persistent CDV
strain, showing centrifugal
compact viral spread with cell-
cell fusion and cytolysis in
center of infected area; anti-
CDV N-PAP. B Virulent
persistent CDV strain, showing
heterogeneous infection pattern
with single infected cells amidst
uninfected ones. Infected cells
are not cytolytic and do not
fuse; anti-CDV N-PAP. C
Persistent CDV, showing viral
antigen in cell processes
rendering the impression of cell
to cell spread; anti-CDV N-
PAP. D Expression of F protein
of A75/17-CDV (persistent
strain) and OP-CDV (cytolytic
strain); Western blot analysis of
cells transfected with empty
vector and plasmids containing
the F genes of either strain. The
positions of the F0 and F1
protein are indicated. In A75/17
CDV, two additional higher
molecular weight bands are
seen corresponding to the two F
precursor proteins (F0* and
F0**). E, F Double
immunoﬂuorescence labeling
for F (red, a) and H (green, b)
proteins of CDV. E Persistent
CDV strain, showing hardly
any colocalization of the two
proteins (arrows). F Non-
persistent CDV strain, showing
clear colocalization of H and F
(circles). A ·40; B ·100; C ·400;
E, F ·200
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relatively long sequence of amino acids preceding an
internal signal peptide allowing the entry of this protein
in endoplasmic reticulum [77]. This long sequence called
Pre sequence is cleaved between amino acids 135 and
136. Comparing sequences of cytolytic, non-persistent
CDV strain with persistent CDV, major diﬀerences be-
tween the two strains were found in the Pre sequence of
the F protein [19]. F protein hybrids were constructed
consisting of various combinations of the Pre sequence
and the F0 of both strains. Transfection of cell lines with
plasmids containing the attachment protein of the
attenuated virus and fusion protein hybrids of either
strains showed that the Pre sequence of the cytolytic
virus greatly inﬂuenced the fusion eﬃciency of the wild-
type F0 and vice versa (studies in progress). Thus, it was
concluded that the Pre sequence, perhaps by modifying
the cleavage eﬃciency of the signal peptide, plays an
important role in the intracellular processing of the F
protein and the eﬃciency of expression of fusogenic
complexes in the cell membrane. Using reverse genetics,
a rescue system for virulent CDV was developed [51].
Infection experiments using recombinant CDV con-
taining various modiﬁcations of the F protein are in
progress.
However, not only viral factors but also cellular
factors appear to play an important role in the fusion
process. Transfection of cell lines with canine SLAM led
to greatly enhanced cell-cell fusion activity following
infection with the wild virus (work in progress). From all
these experiments, it can be concluded that persistence
appears to be related to restriction of syncytia forma-
tion, hence avoiding cytolysis.
Conclusions
There are a number of similarities between canine dis-
temper and murine models of virus-induced demyelina-
tion such as Theiler’s virus and mouse hepatitis virus
infection. As in the mouse models, canine distemper is
also a systemic infection with subsequent involvement of
the nervous system. Both virus-induced oligodendroglial
changes as well as inﬂammatory myelin damage occur in
distemper and in the mouse models. While direct viral
destruction of oligodendrocytes has been found in mice,
there is no clear evidence for oligodendrocyte necrosis or
apoptosis in distemper. In distemper there is a restricted
infection of oligodendrocytes with a dramatic impair-
ment of myelin metabolism. In addition, virus-induced
microglial cell activation probably also plays a role in
the demyelinating process. Since extensive experimental
manipulation of the immune system as in the murine
models is not feasible in dogs, direct comparison be-
tween the canine model and the demyelinating condi-
tions in mice is diﬃcult. There is little doubt, however,
that the local anti-virus immune/inﬂammatory response
contributes to myelin damage in the sense of a bystander
eﬀect in all models, involving a variety of molecules such
as reactive oxygen radicals and cytokines. There is evi-
dence for the triggering of autoimmune reactions in
some of the mouse models, and also in distemper. It is
uncertain to what extent such events play an active role
in myelin damage. So far, there is no conclusive evidence
in our animal models for a virus-induced autoimmune
disease which continues to progress despite complete
clearance of the infectious agent, as proposed in MS.
Rather, common to distemper and mouse models is
virus persistence in the CNS, which appears to be the
key to the progression of the disease. Apparently, the
persistent agent precipitates recurrent immune reactions
even though the infectious load may be very small and
diﬃcult to detect. Therefore, a major remaining chal-
lenge is to understand mechanisms of virus persistence,
which may also lead to new approaches to discover
hidden agents in the nervous system.
Acknowledgement This work was supported by the Swiss National
Science Foundation (grants 32-49506.96 and 31-56686.99) and the
Swiss Multiple Sclerosis Society.
References
1. Alldinger S, Baumga¨rtner W, O¨rvell C (1993) Restricted
expression of viral surface proteins in canine distemper
encephalitis. Acta Neuropathol 85:635–645
2. Alldinger S, Baumga¨rtner W, Moll P van, O¨rvell C (1993) In
vivo and in vitro expression of canine distemper viral proteins
in dogs and non-domestic carnivores. Arch Virol 132:421–428
3. Alldinger S, Wunschmann A, Baumga¨rtner W, Voss C,
Kremmer E (1996) Up-regulation of major histocompatibility
complex class II antigen expression in the central nervous sys-
tem of dogs with spontaneous canine distemper virus enceph-
alitis. Acta Neuropathol 92:273–280
4. Alldinger S, Fonfara S, Kremmer E, Baumgartner W (2000)
Up-regulation of the hyaluronate receptor CD44 in canine
distemper demyelinated plaques. Acta Neuropathol 99:138–146
5. Appel MJ (1969) Pathogenesis of canine distemper. Am J Vet
Res 30:1167–1182
6. Appel MJ, Glickman LT, Raine CS, Tourtellotte WW (1981)
Canine viruses and multiple sclerosis. Neurology 31:944–949
7. Appel MJ, Shek WR, Summers BA (1982) Lymphocyte-medi-
ated immune cytotoxicity in dogs infected with virulent canine
distemper virus. Infect Immun 37:592–600
8. Appel MJG, Yates RA, Foley GL (1994) Canine distemper
epizootic in lions, tigers and leopards in North America. J Vet
Diagn Invest 6:277–288
9. Atkins GJ, McQuaid S, Morris-Downes MM, Galbraith SE,
Amor S, Cosby SL, Sheahan BJ (2000) Transient virus infec-
tion and multiple sclerosis. Rev Med Virol 10:291–303
10. Axthelm MK, Krakowka S (1998) Experimental old dog
encephalitis (ODE) in a gnotobiotic dog Vet Pathol 35:527–534
11. Barben G, Stettler M, Jaggy A, Vandevelde M, Zurbriggen A
(1999) Detection of IgM antibodies against the nucleocapsid
protein of canine distemper virus in dog sera using a dot-blot-
assay. Zentralbl Veterinarmed A. 46:115–121
12. Baumga¨rtner W, O¨rvell C, Reinacher M (1989) Naturally
occurring canine distemper virus encephalitis: distribution and
expression of viral polypeptides in nervous tissues. Acta Neu-
ropathol 78:504–512
13. Blakemore WF, Summers BA, Appel MG (1989) Evidence of
oligodendrocyte infection and degeneration in canine distemper
encephalomyelitis. Acta Neuropathol 77:550–553
66
14. Bollo E, Zurbriggen A, Vandevelde M, Fankhauser R (1986)
Canine distemper virus clearance in chronic inﬂammatory
demyelination. Acta Neuropathol 72:69–73
15. Botteron C, Zurbriggen A, Griot C, Vandevelde M (1992)
Canine distemper virus-immune complexes induce bystander
degeneration of oligodendrocytes. Acta Neuropathol 83:402–
407
16. Bru¨gger M, Jungi TW, Zurbriggen A, Vandevelde M (1992)
Canine distemper virus increases procoagulant activity of
macrophages. Virology 190:616–623
17. Bu¨rge T, Griot C, Vandevelde M, Peterhans E (1989) Antiviral
antibodies stimulate production of reactive oxygen species in
cultured canine brain cells infected with canine distemper virus.
J Virol 63:2790–2797
18. Cerruti Sola S, Kristensen F, Vandevelde M, Bichsel P,
Kihm U (1983) Lymphocyte responsiveness to lectin and
myelin antigens in canine distemper infection in relation to
the development of demyelinating lesions. J Neuroimmunol
4:77–90
19. Cherpillod P, Beck K, Zurbriggen A, Wittek R (1999) Sequence
analysis and expression of the attachment and fusion proteins
of canine distemper virus wild-type strain A75/17. J Virol
73:2263–2269
20. De Keyser J, Wilczak N, Walter JH, Zurbriggen A (2001)
Disappearance of beta-adrenergic receptors on astrocytes in
canine distemper encephalitis: possible implications for the
pathogenesis of multiple sclerosis. Neuroreport 12:191–194
21. Duprex WP, McQuaid S, Hangartner L, Billeter MA, Rima
BK (1999) Observation of measles virus cell-to-cell spread in
astrocytoma cells by using a green ﬂuorescent protein-
expressing recombinant virus. J Virol 73:9568–9575
22. Fazakerley JK, Walker R (2003) Virus demyelination. J Neu-
rovirol 9:148–164
23. Glaus T, Griot C, Richard A, Althaus U, Herschkowitz N,
Vandevelde M (1990) Ultrastructural and biochemical ﬁndings
in brain cell cultures infected with canine distemper virus. Acta
Neuropathol 80:59–67
24. Graber H, Mu¨ller C, Vandevelde M, Zurbriggen A (1995)
Restricted infection with canine distemper virus leads to down-
regulation of myelin gene transcription in cultured oligoden-
drocytes. Acta Neuropathol 90:312–318
25. Griot C, Vandevelde M (1988) Transferrin, carbonic anhydrase
C and ferritin in dissociated murine brain cell cultures.
J Neuroimmunol 18:333–340
26. Griot C, Bu¨rge T, Vandevelde M, Peterhans E (1989) Anti-
body-induced generation of reactive oxygen radicals by brain
macrophages in canine distemper encephalitis: a mechanism for
bystander demyelination. Acta Neuropathol 78:396–403
27. Griot C, Bu¨rge T, Vandevelde M, Peterhans E (1989) By-
stander demyelination through antibody induced macrophage
activation in canine distemper virus infection. Schweiz Arch
Neurol Psychiatr 140:39–41
28. Griot C, Vandevelde M, Richard A, Peterhans E, Stocker R
(1990) Selective degeneration of oligodendrocytes mediated by
reactive oxygen species. Free Radic Res Commun 11:181–193
29. Griot-Wenk M, Griot C, Pﬁster H, Vandevelde M (1991)
Antibody-dependent cellular cytotoxicity in antimyelin anti-
body-induced oligodendrocyte damage in vitro. J Neuroim-
munol 33:145–155
30. Gro¨ne A, Fonfara S, Baumgartner W (2002) Cell type-depen-
dent cytokine expression after canine distemper virus infection.
Viral Immunol 15:493–505
31. Harder TC, Kenter M, Appel MJG, Roelke-Parker ME, Bar-
rett T, Osterhaus ADME (1995) Phylogenetic evidence of ca-
nine distemper virus in Serengeti’s lions. Vaccine 13:521–523
32. Higgins RJ, Krakowka SG, Metzler A, Koestner A (1982)
Primary demyelination in experimental canine distemper virus
induced encephalomyelitis in gnotobiotic dogs. Sequential
immunologic and morphologic ﬁndings. Acta Neuropathol
(Berl) 58:1–8
33. Higgins RJ, Krakowka SG, Metzler AE, Koestner A (1982)
Experimental canine distemper encephalomyelitis in neonatal
gnotobiotic dogs. A sequential ultrastructural study. Acta
Neuropathol (Berl) 57:287–295
34. Higgins RJ, Child G, Vandevelde M (1989) Chronic relapsing
demyelinating encephalomyelitis associated with persistent
spontaneous canine distemper virus infection. Acta Neuropa-
thol 77:441–444
35. Iwatsuki K, Okita M, Ochikubo F, Gemma T, Shin YS, Mi-
yashita N, Mikami T, Kai C (1995) Immunohistochemical
analysis of the lymphoid organs of dogs naturally infected with
canine distemper virus. J Comp Pathol 113:185–290
36. Johnson GC, Fenner WR, Krakowka S (1988) Production of
immunoglobulin G and increased antiviral antibody in cere-
brospinal ﬂuid of dogs with delayed-onset canine distemper
viral encephalitis. J Neuroimmunol 17:237–251
37. Krakowka S (1982) Mechanisms of in vitro immunosuppres-
sion in canine distemper virus infection. J Clin Lab Immunol
8:187–196
38. Krakowka S, McCullough B, Koestner A, Olsen R (1973)
Myelin-speciﬁc autoantibodies associated with central nervous
system demyelination in canine distemper virus infection. Infect
Immun 8:819–827
39. Krakowka S, Higgins RJ, Koestner A (1980) Canine distemper
virus: review of structural and functional modulations in lym-
phoid tissues. Am J Vet Res 41:284–292
40. Kumagai K, Yamaguchi R, Uchida K, Tateyama S (2004)
Lymphoid apoptosis in acute canine distemper. J Vet Med Sci
2004 66:175–181
41. Loﬄer S, Lottspeich F, Lanza F, Azorsa DO, Meulen V ter,
Schneider-Schaulies (1997) CD9, a tetraspan transmembrane
protein, renders cells susceptible to canine distemper virus. J
Virol 71:42–49
42. Markus S, Failing K, Baumgartner W (2002) Increased
expression of pro-inﬂammatory cytokines and lack of up-reg-
ulation of anti-inﬂammatory cytokines in early distemper CNS
lesions. J Neuroimmunol 125:30–41
43. McCullough B, Krakowka S, Koestner A (1974) Experimental
canine distemper virus-induced demyelination. Lab Invest
31:216–222
44. Meertens N, Stoﬀel MH, Cherpillod P, Wittek R, Vandevelde
M, Zurbriggen A (2003) Mechanism of reduction of virus re-
lease and cell-cell fusion in persistent canine distemper virus
infection. Acta Neuropathol 106:303–310
45. Miao Q, Baumgartner W, Failing K, Alldinger S (2003) Phase-
dependent expression of matrix metalloproteinases and their
inhibitors in demyelinating canine distemper encephalitis Acta
Neuropathol 106:486–494
46. Moro L, Sousa Martins A de, Moraes Alves C de, Araujo
Santos FG de, Santos Nunes JE dos, Carneiro RA, Carvalho
R, Vasconcelos AC (2003) Apoptosis in canine distemper. Arch
Virol 148:153–164
47. Mu¨ller C, Fatzer R, Beck K, Vandevelde M, Zurbriggen A
(1995) Studies on canine distemper virus persistence in the
nervous system. Acta Neuropathol 89:438–445
48. Mutinelli F, Vandevelde M, Griot C, Richard A (1989)
Astrocytic infection in canine distemper virus-induced demye-
lination. Acta Neuropathol 77:333–335
49. Osterhaus AD, Groen J, De Vries P, Uytdehaag FG, Klinge-
born B, Zarnke R (1988) Canine distemper virus in seals.
Nature 335:403–404
50. Peeples ME (1991) Paramyxovirus M proteins: pulling it
all together and taking it on the road. In: Kingsbury DW
(ed) The paramyxoviruses. Plenum Press, New York, pp 427–
456
51. Plattet P, Zweifel C, Wiederkehr C, Belloy L, Cherpillod P,
Zurbriggen A, Wittek R (2004) Recovery of a persistent canine
distemper virus expressing the enhanced green ﬂuorescent
protein from cloned cDNA. Virus Res 101:147–153
52. Raine CS (1976) On the development of CNS lesions in natural
canine distemper encephalomyelitis. J Neurol Sci 30:13–28
53. Saunders LZ (1973) Some historical aspects of the neuropa-
thology of canine distemper. Schweiz Arch Neurol Psychiatr
112:341–352
67
54. Scarisbrick IA, Rodriguez M (2003) Hit-Hit and hit-Run:
viruses in the playing ﬁeld of multiple sclerosis. Curr Neurol
Neurosci Rep 3:265–271
55. Scherer HJ (1944) Vergleichende Pathologie des Nervensystems
der Sa¨ugetiere. Georg Thieme, Leipzig
56. Schneider-Schaulies J, Niewiesk S, Schneider-Schaulies S, Me-
ulen V ter (1999) Measles virus in the CNS: the role of viral and
host factors for the establishment and maintenance of a per-
sistent infection. J Neurovirol 5:613–622
57. Schobesberger M, Zurbriggen A, Summerﬁeld A, Vandevelde
M, Griot C (1999) Oligodendroglial degeneration in distemper:
apoptosis or necrosis? Acta Neuropathol 97:179–187
58. Schobesberger M, Zurbriggen A, Doherr MG, Weissenbock H,
Vandevelde M, Lassmann H, Griot C (2002) Demyelination
precedes oligodendrocyte loss in canine distemper virus-in-
duced encephalitis. Acta Neuropathol 103:11–19
59. Seki F, Ono N, Yamaguchi R, Yanagi Y (2003) Eﬃcient iso-
lation of wild strains of canine distemper virus in Vero cells
expressing canine SLAM (CD150) and their adaptability to
marmoset B95a cells. J Virol 77:9943–9950
60. Stein MS, Czub M, Schreiner N, Moore PF, Vandevelde M,
Zurbriggen A, Tipold A (2004) Microglial cell activation in
demyelinating canine distemper lesions. J Neuroimmunol
153:122–131
61. Stettler M, Beck K, Wagner A, Vandevelde M, Zurbriggen A
(1997) Determinants of persistence in canine distemper viruses.
Vet Microbiol 57:83–89
62. Stohlman A, Hinton DR (2001) Viral induced demyelination.
Brain Pathol 11:92–106
63. Summers BA, Appel MJ (1987) Demyelination in canine dis-
temper encephalomyelitis: an ultrastructural analysis. J Neu-
rocytol 16:871–881
64. Summers BA, Greisen HA, Appel MJ (1979) Early events in
canine distemper demyelinating encephalomyelitis. Acta Neu-
ropathol (Berl) 46:1–10
65. Summers BA, Greisen HA, Appel MJ (1984) Canine distemper
encephalomyelitis: variation with virus strain. J Comp Pathol
94:65–75
66. Summers BA, Greisen HA, Appel MJ (1984) Canine distemper
and experimental allergic encephalomyelitis in the dog: com-
parative patterns of demyelination. J Comp Pathol 94:575–589
67. Summers BA, Cummings JF, deLahunta A (1995) Veterinary
neuropathology. Mosby, St. Louis
68. Tipold A, Jaggy A, Zurbriggen A, Vandevelde M (1996)
Neurological signs in canine distemper encephalomyelitis—a
clinical study. Eur J Companion Anim Pract 6:33–38
69. Tipold A, Moore P, Zurbriggen A, Burgener I, Barben G,
Vandevelde M (1999) Early T-cell response in the central ner-
vous system in canine distemper virus infection. Acta Neuro-
pathol 97:45–56
70. Tipold A, Vandevelde M, Wittek R, Moore P, Summerﬁeld A,
Zurbriggen A (2001) Partial protection and intrathecal invasion
of CD8(+) T cells in acute canine distemper virus infection.
Vet Microbiol 83:189–203
71. Vandevelde M, Fankhauser R, Kristensen F, Kristensen B
(1981) Immunoglobulins in demyelinating lesions in canine
distemper encephalitis. An immunohistological study. Acta
Neuropathol 54:31–41
72. Vandevelde M, Higgins RJ, Kristensen B, Kristensen F,
Steck AJ, Kihm U (1982) Demyelination in experimental
canine distemper virus infection: immunological, pathologic,
and immunohistological studies. Acta Neuropathol (Berl)
56:285–293
73. Vandevelde M, Kristensen F, Kristensen B, Steck AJ, Kihm U
(1982) Immunological and pathological ﬁndings in demyelin-
ating encephalitis associated with canine distemper virus
infection. Acta Neuropathol (Berl) 56:1–8
74. Vandevelde M, Zurbriggen A, Dumas M, Palmer D (1985)
Canine distemper virus does not infect oligodendrocytes in vi-
tro. J Neurol Sci 69:133–137
75. Vandevelde M, Zurbriggen A, Higgins RJ, Palmer D (1985)
Spread and distribution of viral antigen in nervous canine
distemper. Acta Neuropathol (Berl) 67:211–218
76. Vandevelde M, Zurbriggen A, Steck A, Bichsel P (1986) Studies
on the intrathecal humoral immune response in canine dis-
temper encephalitis. J Neuroimmunol 11:41–51
77. Von Messling V, Cattaneo R (2002) Amino-terminal precursor
sequence modulates canine distemper virus fusion protein
function. J Virol 76:4172–4180
78. Wisniewski H, Raine CS, Kay WJ (1972) Observations on viral
demyelinating encephalomyelitis. Canine distemper. Lab Invest
26:589–599
79. Wunschmann A, Alldinger S, Kremmer E, Baumga¨rtner W
(1999) Identiﬁcation of CD4+ and CD8+ T cell subsets and B
cells in the brain of dogs with spontaneous acute, subacute-,
and chronic-demyelinating distemper encephalitis. Vet Immu-
nol Immunopathol 67:101–116
80. Wunschmann A, Kremmer E, Baumgartner W (2002) Pheno-
typical characterization of T and B cell areas in lymphoid tis-
sues of dogs with spontaneous distemper. Vet Immunol
Immunopathol 73:83–98
81. Zurbriggen A, Vandevelde M, Dumas M (1986) Secondary
degeneration of oligodendrocytes in canine distemper virus
infection in vitro. Lab Invest 54:424–431
82. Zurbriggen A, Vandevelde M, Dumas M, Griot C, Bollo E
(1987) Oligodendroglial pathology in canine distemper virus
infection in vitro. Acta Neuropathol (Berl) 74:366–373
83. Zurbriggen A, Yamawaki M, Vandevelde M (1993) Restricted
canine distemper virus infection of oligodendrocytes. Lab In-
vest 68:277–284
84. Zurbriggen A, Graber H, Wagner A, Vandevelde M (1995)
Canine distemper persistence in the nervous system is
associated with noncytolytic virus spread. J Virol 69:1678–
1686
85. Zurbriggen A, Schmid I, Graber HU, Vandevelde M (1998)
Oligodendroglial pathology in canine distemper. Acta Neuro-
pathol 95:71–77
68
